Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis - Wikidata - wikimedia - TriplyDB

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

http://www.wikidata.org/entity/Q33714064

about

The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.Biopsy in idiopathic pulmonary fibrosis: back to the future.Fibroblast growth factors and pulmonary fibrosis: it's more complex than it sounds How we will diagnose IPF in the future.Precision medicine in idiopathic pulmonary fibrosis.Tissue remodelling in pulmonary fibrosis.Role of pirfenidone in the management of pulmonary fibrosis.Towards a global initiative for fibrosis treatment (GIFT).Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis.An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.The Lung Likes the Little Fella miR-29.Update in Interstitial Lung Disease 2016.Pathways to Precision Medicine in Idiopathic Pulmonary Fibrosis. Time to Relax?Is personalized medicine a realistic goal in idiopathic pulmonary fibrosis?Idiopathic Pulmonary Fibrosis (IPF): An Overview

P2860

Q33601748-8DEC3EB9-0612-408A-AB25-D8568F26AD55 Q33924950-9C5E01C2-5647-4046-95C5-A78A196584FF Q38634828-11251DCA-B35E-4A6D-83B8-4D15B0AAFFFD Q38663383-56C7AC02-AEE6-454F-B2FF-B10C1A601E2B Q38809139-148C6A0D-A8A0-474F-93DC-D155414D5547 Q38831660-860818B7-D00B-4253-B6B2-D2248EFA4696 Q38832472-E93A362F-ED7A-4CDE-A791-34877A24D8F2 Q39040828-68A0C082-2BAE-4A62-8CAF-8BD9394BEA01 Q39257627-263916A8-938B-408B-8D5A-43DBA2477216 Q47152449-997D9948-EFE1-4C6C-BC11-ADB8A1EB3E10 Q47658743-7D403BEC-42FA-46B2-8B31-E840122637B9 Q47815265-2962D737-91A7-4BEB-B6EE-AFA92CB67CB6 Q47901631-428FDC43-47BD-43DB-BB36-BC1CA558A2E9 Q48204626-740DB1F2-0E97-45E2-889A-E3588EF8A1E7 Q49734357-D064E073-50E5-45C1-A507-36DF70EC904B Q51034273-308BCB3B-8314-48BB-8F3B-5E6F7C9FCE44 Q52718368-52578282-378C-4BDC-8DAC-0B5B947ADC6B Q57170607-75919ACA-D653-4032-834A-59EA1E02EAA9

P2860

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

http://www.wikidata.org/entity/Q33714064

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

@ast

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

@en

type

label

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

@ast

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

@en

prefLabel

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

@ast

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

@en

P1433

Q33714064-83C29E8A-0807-40D0-8A62-C56F537BF864

P1476

Q33714064-0E6B3848-8451-4462-967A-EB9316993089

P2093

Q33714064-5D303C10-0EF5-4A24-A689-275F475EC7DA

Q33714064-641C90CF-FB2D-4443-AF01-102CA9C7E952

Q33714064-B5F54AFD-B198-4257-92EC-7F35AD16039F

Q33714064-D2EF8C02-4D68-499D-9C2E-7E3E4B0B5828

Q33714064-DD5F8709-70E9-4A1E-AF45-96C43380F9B9

P2860

Q33714064-026F6D74-F173-4845-9E2C-9BEEA829282F

Q33714064-0A7E6E51-B8C6-4CE9-8C8E-68ED8A3DA1DA

Q33714064-0AEE11CA-E29C-46ED-B699-9D32976C9940

Q33714064-0CA195E7-2691-40FE-A2CE-16B8334953E3

Q33714064-0CC3C1D5-F6AF-48E6-AF29-4052A2800331

Q33714064-0E63414D-406C-4FDE-B5BB-2836E8757BE3

Q33714064-107CC9A8-0DF3-4206-BD95-E3C86F3B1CB5

Q33714064-131F8DF4-2088-4D7D-B2E6-ED00A9D82972

Q33714064-197BD673-EA69-4AE3-B066-1307B481827E

Q33714064-1F1E3F96-BCA7-45B3-8B44-2A40F5ABDA10

P304

Q33714064-26980B4A-7690-45B7-985F-053DF2E544F8

P31

Q33714064-DBF060DF-DF61-49CF-8B99-8E38A9CFD56C

P356

Q33714064-582898E4-BE20-4D7F-A068-42CC88D400B5

P407

Q33714064-45CE1B2A-77D3-4013-B4DF-D495E1DAFEBD

P433

Q33714064-C2B00EA3-6912-4315-BFFD-75007966AEFC

P478

Q33714064-F1A7D97F-D5AE-4E9D-8DBF-292A23900AEA

P50

Q33714064-6483DF79-A82B-45A6-84B3-76274618D763

Q33714064-7F78B067-C7B2-4298-8B28-95E34E4ACA00

P577

Q33714064-5ECF4431-E3E7-4A23-A01A-C0767D74D932

P698

Q33714064-200A62B6-A968-4A93-A482-AA93D2D63A38

P921

Q33714064-FB944DEB-5388-4A22-8A00-46846C3B7B5C

P932

Q33714064-0D3FEA93-A127-4919-9AA8-0BF7EEA6BE43

P356

RCCM.201601-0169CI

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis

@en

P2093

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

Harold R Collard

http://www.w3.org/2001/XMLSchema#string

Prescott G Woodruff

http://www.w3.org/2001/XMLSchema#string

Robert Brownell

http://www.w3.org/2001/XMLSchema#string

Williamson Z Bradford

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

A mutation in the surfactant protein C gene associated with familial interstitial lung disease

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

High-dose acetylcysteine in idiopathic pulmonary fibrosis

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis

P304

1213-1218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201601-0169CI

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P50

Naftali Kaminski

Pietro Battaglini

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26991475

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5440061

http://www.w3.org/2001/XMLSchema#string